London Strategy published an article by Aparna Kapse on how FDA approval timelines and EMA credibility are shaping deal value, structure, and sequencing in pharma M&A in 2026.
Published
Signal category
Research & Knowledge
Quote
“Aparna Kapse on how FDA approval timelines and EMA credibility are shaping deal value, structure, and sequencing in pharma M&A in 2026”
— London Strategy team
Company
London Strategy
London Strategy is a management and IT consulting firm with a focus on M&A, IT Transformation and Cybersecurity.
- Industry
- Business Consulting and Services
- Location
- London, GB
- Company size
- 15 employees
London Strategy is a specialised management and IT consultancy that drives sustainable transformation, simplifies complexities, enhances productivity, and adds value for clients. We prioritise strong client relationships, effective communication, and efficient project oversight, ensuring success and fostering long-term partnerships as a trusted advisor. Our team works closely with clients to understand the overall objectives and develop a customised plan for implementing change that will lead to sustained results.
Founded 2015